XML 65 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt Obligations - 2027 Term Loan - Narrative (Details)
$ in Thousands
1 Months Ended 3 Months Ended
May 08, 2024
USD ($)
Apr. 01, 2024
USD ($)
Feb. 05, 2024
USD ($)
Apr. 30, 2024
USD ($)
Jan. 31, 2022
USD ($)
item
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Sep. 14, 2022
USD ($)
Jan. 05, 2022
USD ($)
tranche
Apr. 30, 2020
USD ($)
Debt Instrument [Line Items]                    
Debt partial prepayment to be Made     $ 175,000              
Minimum net sales convenant level agreed to be maintained over past year     125,000              
2027 Term Loans                    
Debt Instrument [Line Items]                    
Interest rate           13.84%        
2027 Term Loans | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]                    
Debt Instrument [Line Items]                    
Spread on variable rate           1.00%        
Interest rate           0.26161%        
2027 Term Loans | BioPharma Credit Investments V GP LLC                    
Debt Instrument [Line Items]                    
Principal amount                 $ 300,000  
Number of tranches | tranche                 4  
Quarterly payments | item         5          
Loan agreement covenants, minimum trailing twelve month net sales for current quarter         $ 200,000          
Loan agreement covenants, minimum trailing twelve month net sales for the quarter ended March 30, 2024         $ 210,000          
Mandatory prepayment term         10 days          
2027 Term Loans | BioPharma Credit Investments V GP LLC | Scenario, Plan                    
Debt Instrument [Line Items]                    
Loan agreement covenants, minimum trailing twelve-month net sales continuing through the quarter ended December 31, 2026     $ 125,000              
2027 Term Loans | Additional facility amount | BioPharma Credit Investments V GP LLC                    
Debt Instrument [Line Items]                    
Principal amount         $ 100,000          
2027 Term Loans | Starting April 1, 2023 | BioPharma Credit Investments V GP LLC                    
Debt Instrument [Line Items]                    
Stated interest rate           8.25%        
2027 Term Loans | Subsequent Event                    
Debt Instrument [Line Items]                    
Principal amount   $ 250,000                
Net carrying value $ 75,000                  
Partial prepayment of principal   175,000                
Prepayment fees for partial debt repayment 3,500 6,800                
Outstanding amount paid off $ 75,000 $ 175,000   $ 175,000            
Tranche A Loan, funded January 5, 2022 | BioPharma Credit Investments V GP LLC                    
Debt Instrument [Line Items]                    
Principal amount                 $ 100,000  
Tranche B Loan, funded on March 31, 2022 | BioPharma Credit Investments V GP LLC                    
Debt Instrument [Line Items]                    
Principal amount             $ 100,000      
Tranche C Loan, not funded between April 1, 2022 and March 17, 2023 | BioPharma Credit Investments V GP LLC                    
Debt Instrument [Line Items]                    
Principal amount         50,000          
Tranche D Loan, funded on September 14, 2022 | BioPharma Credit Investments V GP LLC                    
Debt Instrument [Line Items]                    
Principal amount               $ 50,000    
1.5% Convertible Senior Subordinated Notes due 2026 | Convertible Notes                    
Debt Instrument [Line Items]                    
Principal amount                   $ 230,000
Net carrying value           $ 227,220        
Stated interest rate                   1.50%
Remaining unamortized debt discount and debt offering costs           $ 2,780        
Effective interest rate           2.10%        
1.5% Convertible Senior Subordinated Notes due 2026 | BioPharma Credit Investments V GP LLC | Scenario, Plan | Maximum                    
Debt Instrument [Line Items]                    
Principal amount         $ 50,000          
Tranches A, B and D | BioPharma Credit Investments V GP LLC                    
Debt Instrument [Line Items]                    
Remaining unamortized debt discount and debt offering costs           $ 2,500        
Remaining term           2 years 9 months 18 days